Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer

E-ISSN： 1876-1038|10|2|101-110

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.10, Iss.2, 2015-01, pp. : 101-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of the androgen receptor in triple-negative breast cancer

By Shah Payal D Gucalp Ayca Traina Tiffany A

Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. : 351-360

Future Medicine

Access to resources Recommend Favorite

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 252-259

Karger

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Body Mass Index in Triple Negative Breast Cancer

Oncology Research and Treatment, Vol. 38, Iss. 10, 2015-0 ,pp. : 518-522

Karger

Access to resources Recommend Favorite

Triple Negative Breast Cancer: A Review

Current Women's Health Reviews, Vol. 5, Iss. 3, 2009-01 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite